A phase I, open-label, multi-center, dose escalation study of oral NVP-CGM097, a p53/HDM2-protein-protein interaction inhibitor, in adult patients with selected advanced solid tumors

Autor:	Christophe Meille, Ensar Halilovic, Sebastian Bauer, Daniel Shao-Weng Tan, P. A. Cassier, George D. Demetri, A. Kumar, Nelson Guerreiro, Reinhard Dummer, L. Van Bree, Sébastien Jeay, Jens Wuerthner
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	0301 basic medicine Adult patients business.industry Medizin Hematology Pharmacology Protein–protein interaction 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Dose escalation Medicine Open label NVP-CGM097 business
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b4154ac87d4f0d3af866f17aa0a5df Zobrazit plný text záznamu